161 related articles for article (PubMed ID: 21443033)
1. Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis.
Altarescu G; Rachmilewitz D; Zevin S
Isr Med Assoc J; 2011 Feb; 13(2):87-90. PubMed ID: 21443033
[TBL] [Abstract][Full Text] [Related]
2. An association of CYP2A6 genotype and smoking topography.
Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
[TBL] [Abstract][Full Text] [Related]
3. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
Carter B; Long T; Cinciripini P
Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
[TBL] [Abstract][Full Text] [Related]
4. Associations of CYP2A6 genotype with smoking behaviors in southern China.
Liu T; David SP; Tyndale RF; Wang H; Zhou Q; Ding P; He YH; Yu XQ; Chen W; Crump C; Wen XZ; Chen WQ
Addiction; 2011 May; 106(5):985-94. PubMed ID: 21205058
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI.
Tang DW; Hello B; Mroziewicz M; Fellows LK; Tyndale RF; Dagher A
Neuroimage; 2012 May; 60(4):2136-43. PubMed ID: 22342802
[TBL] [Abstract][Full Text] [Related]
6. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
[TBL] [Abstract][Full Text] [Related]
7. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
[TBL] [Abstract][Full Text] [Related]
8. Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
Kwon JT; Nakajima M; Chai S; Yom YK; Kim HK; Yamazaki H; Sohn DR; Yamamoto T; Kuroiwa Y; Yokoi T
Pharmacogenetics; 2001 Jun; 11(4):317-23. PubMed ID: 11434509
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.
Gambier N; Batt AM; Marie B; Pfister M; Siest G; Visvikis-Siest S
Pharmacogenomics J; 2005; 5(4):271-5. PubMed ID: 15940289
[TBL] [Abstract][Full Text] [Related]
10. Associations of CYP2A6 Gene Polymorphism with Smoking Status Among Jordanians: Gender-Related Differences.
Hammad HM; Imraish A; Azab B; Best AM; Khader YS; Zihlif M
Curr Drug Metab; 2019; 20(9):765-770. PubMed ID: 31453782
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between smoking behavior in young people and CYP2A6 gene polymorphisms, between them and personality traits assessed by NEO-FFI].
Waga C; Iwahashi K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Aug; 41(4):380-6. PubMed ID: 17037346
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
[TBL] [Abstract][Full Text] [Related]
13. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
[TBL] [Abstract][Full Text] [Related]
14. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Ho MK; Mwenifumbo JC; Al Koudsi N; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2009 Jun; 85(6):635-43. PubMed ID: 19279561
[TBL] [Abstract][Full Text] [Related]
15. CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers.
Chenoweth MJ; O'Loughlin J; Sylvestre MP; Tyndale RF
Pharmacogenet Genomics; 2013 Apr; 23(4):232-5. PubMed ID: 23462429
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.
Yoshida R; Nakajima M; Watanabe Y; Kwon JT; Yokoi T
Br J Clin Pharmacol; 2002 Nov; 54(5):511-7. PubMed ID: 12445030
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
18. Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population.
Tang X; Guo S; Sun H; Song X; Jiang Z; Sheng L; Zhou D; Hu Y; Chen D
Pharmacogenet Genomics; 2009 May; 19(5):345-52. PubMed ID: 19415821
[TBL] [Abstract][Full Text] [Related]
19. Effects of whole deletion of CYP2A6 on nicotine metabolism in humans.
Zhang X; Ameno K; Ameno S; Kinoshita H; Kubota T; Kumihashi M; Mostofa J; Iwahashi K; Ijiri I
Drug Chem Toxicol; 2002 May; 25(2):203-13. PubMed ID: 12024803
[TBL] [Abstract][Full Text] [Related]
20. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents.
Huang S; Cook DG; Hinks LJ; Chen XH; Ye S; Gilg JA; Jarvis MJ; Whincup PH; Day IN
Pharmacogenet Genomics; 2005 Dec; 15(12):839-50. PubMed ID: 16272956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
